EQT
57
-2
PM
62
-2
PNC
64
4
KEY
46
3
IR
66
3
ES
34
3
IPG
56
3
GOOGL
40
-5
PEP
48
6
GS
75
2
ACN
52
3
EXC
53
-3
UA
50
-9
XRX
44
3
CFG
70
6
CMG
72
5
PVH
62
5
KLAC
47
4
FE
50
-2
CSCO
67
4
EQT
57
-2
PM
62
-2
PNC
64
4
KEY
46
3
IR
66
3
ES
34
3
IPG
56
3
GOOGL
40
-5
PEP
48
6
GS
75
2
ACN
52
3
EXC
53
-3
UA
50
-9
XRX
44
3
CFG
70
6
CMG
72
5
PVH
62
5
KLAC
47
4
FE
50
-2
CSCO
67
4
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

TKPHF
Takeda Pharmaceutical

Last Price:
25.26
Seasonality Move:
5.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Takeda Pharmaceutical Price Quote

$25.26
+0.00 (+-1.14%)
(Updated: November 23, 2024 at 5:57 AM ET)

Takeda Pharmaceutical Key Stats

Sell
20
Takeda Pharmaceutical (TKPHF) is a Sell
Day range:
$24.38 - $25.26
52-week range:
$23.80 - $30.90
Dividend yield:
5.13%
P/E ratio:
39.98
P/S ratio:
1.33
P/B ratio:
0.83%
Volume:
345
Avg. volume:
6.8K
1-year change:
-7.62%
Market cap:
$40B
Revenue:
$29.5B
EPS:
$1.21

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TKPHF Cash Flow From Operations?
    Cash flow from operations (TTM) is $6B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $306.8M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TKPHF return on invested capital is 2.37%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1.91%
  • What Is TKPHF Return On Equity?
    ROE is a measure of profitability and is 4.01%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.64% 6.41%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many TKPHF shares are owned by institutional investors?
    552.8M TKPHF shares are owned by institutional investors
  • How many TKPHF shares are owned by insiders?
    0 TKPHF shares are owned by insiders